The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Cardiovasc. Med.
Sec. Coronary Artery Disease
Volume 11 - 2024 |
doi: 10.3389/fcvm.2024.1386318
The triglyceride-glucose index is associated with No-reflow phenomenon in STEMI patients with Type 2 diabetes after percutaneous coronary intervention
Provisionally accepted- 1 Department of Cardiology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shaanxi Province, China
- 2 School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia Hui Region, China
- 3 Department of Gynaecology and obstetrics, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, China
- 4 Heart Centre & Department of Cardiovascular Diseases, General Hospital of Ningxia Medical University, Yinchuan, China
- 5 Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, China
The relationship between the triglyceride-glucose (TyG) index and no-reflow phenomenon after percutaneous coronary intervention (PCI) in patients with type 2 diabetes mellitus (T2DM) and acute ST-segment elevation myocardial infarction (STEMI) remains unclear. The aim of this study was to investigate the relationship between baseline TyG index and no-reflow phenomenon in STEMI patients with T2DM after PCI.This study enrolled 695 patients with T2DM and STEMI from the General Hospital of Ningxia Medical University (2014)(2015)(2016)(2017)(2018)(2019). Patients were divided into tertiles according to the TyG index levels. The incidence of no-reflow phenomenon was recorded. A multivariate regression model was developed to analyze the association between baseline TyG index and no-reflow phenomenon. The linear association between baseline TyG index and no-reflow phenomenon was explored using smooth curve fitting with parallel subgroup analyses. Receiver operating characteristic (ROC) curve were generated to determine predictive power of TyG index.A multivariate logistic regression model revealed that the TyG index was an independent risk factor of no-reflow phenomenon [OR=3.23,95%CI: 2.15-4.86, P<0.001], and the occurrence of no-reflow phenomenon increased gradually with the increase of TyG index tertile interval (P < 0.001). Smooth curve fitting showed that TyG index was linearly related to the risk of no-reflow. Subgroup analysis showed that they participated in this positive correlation. The area under ROC curve (AUC) of the TyG index for evaluating the occurrence of No-reflow was 0.710 (95% CI 0.640-0.780; p<0.01).Conclusions TyG index is independently associated with no-reflow phenomenon, suggesting that the simple index of TyG index can be used for risk assessment of no-reflow phenomenon after PCI in STEMI patients with T2DM.
Keywords: Insulin resistance (IR), Triglyceride-glucose index (TyG index), Type 2 diabetes mellitus (T2DM), ST-segment elevation myocardial infarction (STEMI), no-reflow phenomenon(NRP)
Received: 15 Feb 2024; Accepted: 26 Aug 2024.
Copyright: © 2024 Jin, Ma, Wu, Ma, Ma and Jia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ping Jin, Department of Cardiology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an, 710004, Shaanxi Province, China
Shaobin Jia, Heart Centre & Department of Cardiovascular Diseases, General Hospital of Ningxia Medical University, Yinchuan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.